Sep 01, 2016 12:00 pm UTC| Business
PALO ALTO, Calif., Sept. 01, 2016 -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel San Francisco. ...
Aduro Biotech Announces New Corporate Offices and Laboratory Space
Sep 01, 2016 12:00 pm UTC| Business
BERKELEY, Calif., Sept. 01, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the opening of a new corporate office and laboratory facility, which will serve as the company’s new global headquarters for its U.S....
Achaogen Completes Patient Enrollment in Phase 3 EPIC Clinical Trial of Plazomicin
Sep 01, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2016 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
Sep 01, 2016 12:00 pm UTC| Business
WALTHAM, Mass., Sept. 01, 2016 -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...
Sep 01, 2016 12:00 pm UTC| Business
On a project by project basis, Horizon to co-develop and commercialise IHC Reference Standards with Ventana Medical Systems, Inc. (a member of the Roche Group and innovator of tissue-based diagnostic solutions) to support...
Sep 01, 2016 11:46 am UTC| Business
MAHWAH, N.J., Sept. 01, 2016 -- Radware® (NASDAQ:RDWR), a leading provider of cyber security and application delivery solutions ensuring optimal service levels for applications in virtual, cloud, and software-defined...
ADMA Biologics to Present at Upcoming Investor Conferences
Sep 01, 2016 11:38 am UTC| Business
RAMSEY, N.J., Sept. 01, 2016 -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the proposed...